Truveta Launches Live Link Platform to Expand Real-World Evidence Capabilities

Truveta has shared an update.

The company announced the launch of Truveta Live Link, a new solution designed to connect life sciences companies’ proprietary data on devices, diagnostics, and therapies with Truveta’s continuously updated, regulatory-grade real-world clinical data. The platform aims to provide a more comprehensive, forward-looking view of the patient journey to support real-world evidence generation across health economics and outcomes research (HEOR), regulatory, commercial, and market access use cases. Truveta highlights capabilities such as daily updated electronic health record data, integrated secure data storage, and governance within a single solution.

For investors, this product launch signals an expansion of Truveta’s value proposition in the real-world evidence and clinical data analytics market, an area of growing importance for pharmaceutical, medtech, and diagnostics companies seeking to accelerate evidence generation and regulatory submissions. If Truveta Live Link gains adoption, it could create recurring, high-value enterprise relationships and increase switching costs for customers by centralizing multiple data and governance functions on a single platform. The focus on regulatory-grade data and support for prospective research may also position Truveta competitively against other real-world data providers, potentially strengthening its industry standing and revenue growth prospects in the medium term. However, financial impact will depend on pricing, customer uptake, and the company’s ability to differentiate its solution in a crowded data and analytics market.